Janney Montgomery Scott LLC Has $14.17 Million Stock Position in Agilent Technologies, Inc. $A

Janney Montgomery Scott LLC reduced its position in Agilent Technologies, Inc. (NYSE:A) by 13.2% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 120,108 shares of the medical research company’s stock after selling 18,235 shares during the period. Janney Montgomery Scott LLC’s holdings in Agilent Technologies were worth $14,174,000 as of its most recent filing with the SEC.

Other hedge funds have also bought and sold shares of the company. Stone House Investment Management LLC acquired a new stake in Agilent Technologies during the first quarter worth approximately $30,000. Opal Wealth Advisors LLC acquired a new stake in Agilent Technologies during the first quarter worth approximately $31,000. Ransom Advisory Ltd acquired a new stake in Agilent Technologies during the first quarter worth approximately $32,000. Central Pacific Bank Trust Division acquired a new stake in Agilent Technologies during the second quarter worth approximately $33,000. Finally, Zions Bancorporation National Association UT acquired a new stake in Agilent Technologies during the first quarter worth approximately $38,000.

Agilent Technologies Stock Performance

Shares of NYSE:A opened at $141.91 on Friday. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $153.84. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71. The stock has a market capitalization of $40.23 billion, a price-to-earnings ratio of 33.31, a price-to-earnings-growth ratio of 4.53 and a beta of 1.26. The company’s 50 day simple moving average is $122.80 and its 200 day simple moving average is $116.41.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The firm had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same quarter last year, the business posted $1.32 earnings per share. The company’s quarterly revenue was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, research analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th will be given a $0.248 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is currently 23.24%.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Barclays raised their price objective on shares of Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a research report on Thursday. Robert W. Baird raised their target price on shares of Agilent Technologies from $141.00 to $142.00 and gave the stock an “outperform” rating in a report on Thursday, August 28th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Agilent Technologies in a report on Saturday, September 27th. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Friday. Finally, Wells Fargo & Company raised their target price on shares of Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a report on Monday, September 15th. Six analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $142.17.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.